Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-17 Purchase | 2022-03-17 9:27 pm | Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer | 16,500 | $1.198 | $19,767 | 266,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-16 Disposition | 2022-12-20 4:05 pm | N/A N/A | Oncocyte Corp | OCX | Paulsen Gisela Former President and COO | 542,188 | $0 | 624,312 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:22 pm | N/A N/A | Oncocyte Corp | OCX | Paulsen Gisela President & COO | 525,000 | $0 | 541,500 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:27 pm | N/A 2032-03-15 | Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer | 250,000 | $0 | 266,500 (Direct) | View |
Ownership | 2021-10-14 4:05 pm | N/A 2031-10-04 | Oncocyte Corp | OCX | Paulsen Gisela Chief Operating Officer | 0 | $0 | 375,000 (Direct) | View |
| 2020-04-20 Option Award | 2020-04-22 4:18 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Paulsen Gisela Gen Mgr, Precision Oncology | 66,267 | $0 | 66,267 (Direct) | View |